Comparation Between Needles for EUS-guided Sampling of Solid Pancreatic Lesions
Primary Purpose
Pancreatic Neoplasms
Status
Unknown status
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
needle punction
Sponsored by
About this trial
This is an interventional diagnostic trial for Pancreatic Neoplasms focused on measuring accuracy, pancreatic cancer, endoscopic ultrasound-guided
Eligibility Criteria
Inclusion Criteria:
- solid pancreatic lesion larger than 15 mm
Exclusion Criteria:
- pancreatic cystic lesion
- lesion not detected in EUS
- abnormal coagulation parameters (INR> 2, platelet count < 50,000)
Sites / Locations
- ICESPRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
Experimental
Arm Label
Standard FNA 22G needle
Franseen 22G needle
Arm Description
The pancreatic mass will be puncture, for expert endoscopist, with a standard FNA 22G needle
The pancreatic mass will be puncture, for expert endoscopist, with a FNB 22G needle. The sequence of the use of needles will be randomized.
Outcomes
Primary Outcome Measures
Compare the diagnostic yield
compare the diagnostic yield between two EUS needles
Secondary Outcome Measures
extra passes with each needle
number of extra passes with each needle required to reach adequate core, possibility to perform immunohistochemistry
perform immunohistochemistry
need to perform immunohistochemistry to reach the result
adverse event rate
to assess the adverse event rate
Full Information
NCT ID
NCT04877340
First Posted
April 20, 2021
Last Updated
May 3, 2021
Sponsor
Instituto do Cancer do Estado de São Paulo
Collaborators
Boston Scientific Corporation
1. Study Identification
Unique Protocol Identification Number
NCT04877340
Brief Title
Comparation Between Needles for EUS-guided Sampling of Solid Pancreatic Lesions
Official Title
Prospective Randomized Study Comparing the 25-gauge Franseen Needle and the 25-gauge Standard Needle for EUS-guided Fine-needle Sampling of Solid Pancreatic Lesions Without Rapid on Site Evaluation
Study Type
Interventional
2. Study Status
Record Verification Date
May 2021
Overall Recruitment Status
Unknown status
Study Start Date
November 26, 2020 (Actual)
Primary Completion Date
November 2022 (Anticipated)
Study Completion Date
April 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Instituto do Cancer do Estado de São Paulo
Collaborators
Boston Scientific Corporation
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This is a randomized study in order to compare the diagnostic yield (primary outcome) of EUS-guided sampling of pancreatic solid lesions obtained with the 25-gauge Franseen and the 25-gauge standard needle in patients undergoing EUS-guided sampling of pancreatic solid masses without ROSE. Secondary outcomes are the number of extra passes with each needle required to reach adequate core, possibility to perform immunohistochemistry and the adverse event rate.
Detailed Description
This is a randomized trial conducted at a unique center. The aim of this study is to compare the diagnostic yield (primary outcome) of EUS-guided sampling of pancreatic solid lesions obtained with the 25-gauge Franseen and the 25-gauge standard needle in patients undergoing EUS-guided sampling of pancreatic solid masses without ROSE. Secondary outcomes are the number of extra passes with each needle required to reach adequate core, possibility to perform immunohistochemistry and the adverse event rate.
Patients with a suspected solid pancreatic lesion larger than 15 mm, identified by CT or MRI and referred to EUS-guided sampling will be eligible for inclusion. Patients will be excluded in case of cystic lesion, or the lesion was not detected in EUS, or if the coagulation parameters are abnormal (INR> 2, platelet count < 50,000). The pancreatic mass will be puncture, for expert endoscopist, firstly with a needle according to randomization, followed by another one. Will be make a touch print with the specimen obtained with the needles and, subsequently, all the specimen will be put in formaldehyde solution for cell-block analysis.
Diagnostic yield of cell block will be defined as enough histologic tissue core containing pancreatic parenchyma or tumor with dysplastic cells enough for the correct tissue diagnosis. In the presence of malignant tissue in core specimens, it will be calculated the proportion of the area positive for malignancy compared to the total area of the core and then the each needle yield will be defined.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pancreatic Neoplasms
Keywords
accuracy, pancreatic cancer, endoscopic ultrasound-guided
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
50 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Standard FNA 22G needle
Arm Type
Other
Arm Description
The pancreatic mass will be puncture, for expert endoscopist, with a standard FNA 22G needle
Arm Title
Franseen 22G needle
Arm Type
Experimental
Arm Description
The pancreatic mass will be puncture, for expert endoscopist, with a FNB 22G needle. The sequence of the use of needles will be randomized.
Intervention Type
Device
Intervention Name(s)
needle punction
Intervention Description
EUS-guided sampling of pancreatic solid lesions obtained with the 22-gauge
Primary Outcome Measure Information:
Title
Compare the diagnostic yield
Description
compare the diagnostic yield between two EUS needles
Time Frame
2 years
Secondary Outcome Measure Information:
Title
extra passes with each needle
Description
number of extra passes with each needle required to reach adequate core, possibility to perform immunohistochemistry
Time Frame
2 years
Title
perform immunohistochemistry
Description
need to perform immunohistochemistry to reach the result
Time Frame
2 years
Title
adverse event rate
Description
to assess the adverse event rate
Time Frame
2 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
- solid pancreatic lesion larger than 15 mm
Exclusion Criteria:
pancreatic cystic lesion
lesion not detected in EUS
abnormal coagulation parameters (INR> 2, platelet count < 50,000)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
FAUZE MALUF-FILHO, PHD
Phone
+55 (11)38932000
Email
fauze.maluf@terra.om.br
First Name & Middle Initial & Last Name or Official Title & Degree
GABRIELA PADUANI, MD
Phone
+55(11)944605119
Email
gabrielapaduani@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
FAUZE MALUF-FILHO, PHD
Organizational Affiliation
ICESP/FMUSP
Official's Role
Principal Investigator
Facility Information:
Facility Name
ICESP
City
São Paulo
State/Province
Sao Paulo
ZIP/Postal Code
01246-000
Country
Brazil
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
ICESP
First Name & Middle Initial & Last Name & Degree
FAUZE MALUF-FILHO, PHD
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
23307148
Citation
Madhoun MF, Wani SB, Rastogi A, Early D, Gaddam S, Tierney WM, Maple JT. The diagnostic accuracy of 22-gauge and 25-gauge needles in endoscopic ultrasound-guided fine needle aspiration of solid pancreatic lesions: a meta-analysis. Endoscopy. 2013;45(2):86-92. doi: 10.1055/s-0032-1325992. Epub 2013 Jan 10.
Results Reference
background
PubMed Identifier
19117242
Citation
Puri R, Vilmann P, Saftoiu A, Skov BG, Linnemann D, Hassan H, Garcia ES, Gorunescu F. Randomized controlled trial of endoscopic ultrasound-guided fine-needle sampling with or without suction for better cytological diagnosis. Scand J Gastroenterol. 2009;44(4):499-504. doi: 10.1080/00365520802647392.
Results Reference
background
PubMed Identifier
22695205
Citation
Wani S, Early D, Kunkel J, Leathersich A, Hovis CE, Hollander TG, Kohlmeier C, Zelenka C, Azar R, Edmundowicz S, Collins B, Liu J, Hall M, Mullady D. Diagnostic yield of malignancy during EUS-guided FNA of solid lesions with and without a stylet: a prospective, single blind, randomized, controlled trial. Gastrointest Endosc. 2012 Aug;76(2):328-35. doi: 10.1016/j.gie.2012.03.1395. Epub 2012 Jun 12.
Results Reference
background
PubMed Identifier
21535194
Citation
Itoi T, Sofuni A, Itokawa F, Irisawa A, Khor CJ, Rerknimitr R. Current status of diagnostic endoscopic ultrasonography in the evaluation of pancreatic mass lesions. Dig Endosc. 2011 May;23 Suppl 1:17-21. doi: 10.1111/j.1443-1661.2011.01132.x.
Results Reference
background
PubMed Identifier
17592229
Citation
Levy MJ. Endoscopic ultrasound-guided trucut biopsy of the pancreas: prospects and problems. Pancreatology. 2007;7(2-3):163-6. doi: 10.1159/000104240. Epub 2007 Jun 21.
Results Reference
background
PubMed Identifier
21592873
Citation
Fabbri C, Polifemo AM, Luigiano C, Cennamo V, Baccarini P, Collina G, Fornelli A, Macchia S, Zanini N, Jovine E, Fiscaletti M, Alibrandi A, D'Imperio N. Endoscopic ultrasound-guided fine needle aspiration with 22- and 25-gauge needles in solid pancreatic masses: a prospective comparative study with randomisation of needle sequence. Dig Liver Dis. 2011 Aug;43(8):647-52. doi: 10.1016/j.dld.2011.04.005. Epub 2011 May 17.
Results Reference
background
PubMed Identifier
29343303
Citation
Wang Y, Chen Q, Wang J, Wu X, Duan Y, Yin P, Guo Q, Hou W, Cheng B. Comparison of modified wet suction technique and dry suction technique in endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) for solid lesions: study protocol for a randomized controlled trial. Trials. 2018 Jan 17;19(1):45. doi: 10.1186/s13063-017-2380-y.
Results Reference
background
PubMed Identifier
26743106
Citation
Kim HJ, Jung YS, Park JH, Park DI, Cho YK, Sohn CI, Jeon WK, Kim BI, Choi KY, Ryu S. Endosonographer's macroscopic evaluation of EUS-FNAB specimens after interactive cytopathologic training: a single-center prospective validation cohort study. Surg Endosc. 2016 Oct;30(10):4184-92. doi: 10.1007/s00464-015-4727-3. Epub 2016 Jan 7.
Results Reference
background
PubMed Identifier
28737285
Citation
Sadaf S, Loya A, Akhtar N, Yusuf MA. Role of endoscopic ultrasound-guided-fine needle aspiration biopsy in the diagnosis of lymphoma of the pancreas: A clinicopathological study of nine cases. Cytopathology. 2017 Dec;28(6):536-541. doi: 10.1111/cyt.12442. Epub 2017 Jul 24.
Results Reference
background
PubMed Identifier
29280329
Citation
Mohanty SK, Pradhan D, Sharma S, Sharma A, Patnaik N, Feuerman M, Bonasara R, Boyd A, Friedel D, Stavropoulos S, Gupta M. Endoscopic ultrasound guided fine-needle aspiration: What variables influence diagnostic yield? Diagn Cytopathol. 2018 Apr;46(4):293-298. doi: 10.1002/dc.23883. Epub 2017 Dec 27.
Results Reference
background
PubMed Identifier
1568614
Citation
Vilmann P, Jacobsen GK, Henriksen FW, Hancke S. Endoscopic ultrasonography with guided fine needle aspiration biopsy in pancreatic disease. Gastrointest Endosc. 1992 Mar-Apr;38(2):172-3. doi: 10.1016/s0016-5107(92)70385-x. No abstract available.
Results Reference
result
PubMed Identifier
21483464
Citation
Iglesias-Garcia J, Dominguez-Munoz JE, Abdulkader I, Larino-Noia J, Eugenyeva E, Lozano-Leon A, Forteza-Vila J. Influence of on-site cytopathology evaluation on the diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) of solid pancreatic masses. Am J Gastroenterol. 2011 Sep;106(9):1705-10. doi: 10.1038/ajg.2011.119. Epub 2011 Apr 12.
Results Reference
result
PubMed Identifier
21420083
Citation
Iglesias-Garcia J, Poley JW, Larghi A, Giovannini M, Petrone MC, Abdulkader I, Monges G, Costamagna G, Arcidiacono P, Biermann K, Rindi G, Bories E, Dogloni C, Bruno M, Dominguez-Munoz JE. Feasibility and yield of a new EUS histology needle: results from a multicenter, pooled, cohort study. Gastrointest Endosc. 2011 Jun;73(6):1189-96. doi: 10.1016/j.gie.2011.01.053. Epub 2011 Mar 21.
Results Reference
result
PubMed Identifier
27878861
Citation
Bang JY, Hebert-Magee S, Hasan MK, Navaneethan U, Hawes R, Varadarajulu S. Endoscopic ultrasonography-guided biopsy using a Franseen needle design: Initial assessment. Dig Endosc. 2017 May;29(3):338-346. doi: 10.1111/den.12769. Epub 2016 Dec 20.
Results Reference
result
Learn more about this trial
Comparation Between Needles for EUS-guided Sampling of Solid Pancreatic Lesions
We'll reach out to this number within 24 hrs